James P. Driscoll

845 total citations
21 papers, 379 citations indexed

About

James P. Driscoll is a scholar working on Pharmacology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, James P. Driscoll has authored 21 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 10 papers in Molecular Biology and 5 papers in Organic Chemistry. Recurrent topics in James P. Driscoll's work include Pharmacogenetics and Drug Metabolism (13 papers), Biochemical and Molecular Research (5 papers) and Synthesis and Biological Evaluation (4 papers). James P. Driscoll is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Biochemical and Molecular Research (5 papers) and Synthesis and Biological Evaluation (4 papers). James P. Driscoll collaborates with scholars based in United States, France and Netherlands. James P. Driscoll's co-authors include Amit S. Kalgutkar, Kevin DeMent, David L. Bourdet, Patrick Brassil, Timothy J. Carlson, Jayaprakasam Bolleddula, Philip Worboys, Marc Evanchik, Mark P. Grillo and S. Cyrus Khojasteh and has published in prestigious journals such as Clinical Infectious Diseases, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

James P. Driscoll

20 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James P. Driscoll United States 10 131 110 83 81 65 21 379
J. Kent Rinehart United States 10 193 1.5× 36 0.3× 106 1.3× 23 0.3× 101 1.6× 23 461
Paresh K. Patel India 11 145 1.1× 29 0.3× 252 3.0× 49 0.6× 25 0.4× 25 553
Yan Xia China 14 165 1.3× 45 0.4× 164 2.0× 215 2.7× 30 0.5× 36 646
James Mitroka United States 12 156 1.2× 145 1.3× 26 0.3× 79 1.0× 16 0.2× 22 487
Faraz Kazmi United States 10 194 1.5× 246 2.2× 42 0.5× 43 0.5× 39 0.6× 17 591
Giovanni Cianchetta United States 9 270 2.1× 31 0.3× 67 0.8× 53 0.7× 27 0.4× 10 461
Ellen A. Cannady United States 11 87 0.7× 74 0.7× 43 0.5× 15 0.2× 25 0.4× 21 456
Michelle K. Dennehy United States 7 306 2.3× 89 0.8× 40 0.5× 25 0.3× 26 0.4× 10 582
Adria Colletti United States 13 131 1.0× 90 0.8× 59 0.7× 18 0.2× 25 0.4× 24 372
Olaf Kuhlmann Switzerland 14 88 0.7× 64 0.6× 27 0.3× 33 0.4× 41 0.6× 27 427

Countries citing papers authored by James P. Driscoll

Since Specialization
Citations

This map shows the geographic impact of James P. Driscoll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James P. Driscoll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James P. Driscoll more than expected).

Fields of papers citing papers by James P. Driscoll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James P. Driscoll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James P. Driscoll. The network helps show where James P. Driscoll may publish in the future.

Co-authorship network of co-authors of James P. Driscoll

This figure shows the co-authorship network connecting the top 25 collaborators of James P. Driscoll. A scholar is included among the top collaborators of James P. Driscoll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James P. Driscoll. James P. Driscoll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jackson, Klarissa D., Upendra A. Argikar, Sungjoon Cho, et al.. (2022). Bioactivation and reactivity research advances – 2021 year in review. Drug Metabolism Reviews. 54(3). 246–281.
2.
Khojasteh, S. Cyrus, Upendra A. Argikar, James P. Driscoll, et al.. (2021). Novel advances in biotransformation and bioactivation research – 2020 year in review. Drug Metabolism Reviews. 53(3). 384–433. 6 indexed citations
3.
Driscoll, James P., et al.. (2020). Metabolism and Bioactivation: It’s Time to Expect the Unexpected. Journal of Medicinal Chemistry. 63(12). 6303–6314. 23 indexed citations
4.
Kalgutkar, Amit S. & James P. Driscoll. (2020). Is there enough evidence to classify cycloalkyl amine substituents as structural alerts?. Biochemical Pharmacology. 174. 113796–113796. 16 indexed citations
5.
6.
Carlson, Timothy J., et al.. (2019). Metabolite Profiling and Reaction Phenotyping for the in Vitro Assessment of the Bioactivation of Bromfenac. Chemical Research in Toxicology. 33(1). 249–257. 7 indexed citations
7.
Khojasteh, S. Cyrus, Namandjé N. Bumpus, James P. Driscoll, et al.. (2019). Biotransformation and bioactivation reactions – 2018 literature highlights. Drug Metabolism Reviews. 51(2). 121–161. 7 indexed citations
8.
Driscoll, James P., et al.. (2018). Role of Glucuronidation and P450 Oxidation in the Bioactivation of Bromfenac. Chemical Research in Toxicology. 31(4). 223–230. 8 indexed citations
9.
Grillo, Mark P., John C. L. Erve, Ryan A. Dick, et al.. (2018). In vitroandin vivopharmacokinetic characterization of mavacamten, a first-in-class small molecule allosteric modulator of beta cardiac myosin. Xenobiotica. 49(6). 718–733. 76 indexed citations
10.
Sodhi, Jasleen K., et al.. (2017). Inhibitory Effects of Trapping Agents of Sulfur Drug Reactive Intermediates against Major Human Cytochrome P450 Isoforms. International Journal of Molecular Sciences. 18(7). 1553–1553. 6 indexed citations
11.
Fan, Peter W., Dawei Zhang, Jason Halladay, James P. Driscoll, & S. Cyrus Khojasteh. (2016). Going Beyond Common Drug Metabolizing Enzymes: Case Studies of Biotransformation Involving Aldehyde Oxidase, γ-Glutamyl Transpeptidase, Cathepsin B, Flavin-Containing Monooxygenase, and ADP-Ribosyltransferase. Drug Metabolism and Disposition. 44(8). 1253–1261. 19 indexed citations
12.
Le, Hoa Thi, Peter W. Fan, Susan Wong, et al.. (2016). Elucidating the Mechanism of Tofacitinib Oxidative Decyanation. Drug Metabolism Letters. 10(2). 136–143. 6 indexed citations
13.
Bolleddula, Jayaprakasam, Kevin DeMent, James P. Driscoll, et al.. (2014). Biotransformation and bioactivation reactions of alicyclic amines in drug molecules. Drug Metabolism Reviews. 46(3). 379–419. 60 indexed citations
14.
Driscoll, James P., Steven L. McAfee, Thomas R. Spitzer, et al.. (2011). Treatment of Parainfluenza 3 Infection With DAS181 in a Patient After Allogeneic Stem Cell Transplantation. Clinical Infectious Diseases. 53(7). e77–e80. 39 indexed citations
15.
Zhang, Chenghong, Jane R. Kenny, Hoa Thi Le, et al.. (2011). Novel Mechanism for Dehalogenation and Glutathione Conjugation of Dihalogenated Anilines in Human Liver Microsomes: Evidence foripsoGlutathione Addition. Chemical Research in Toxicology. 24(10). 1668–1677. 11 indexed citations
16.
Brissette, William H., Matthew F. Brown, Jeffrey Casavant, et al.. (2010). Structure–activity relationships and hepatic safety risks of thiazole agonists of the thrombopoietin receptor. Bioorganic & Medicinal Chemistry Letters. 20(14). 4069–4072. 7 indexed citations
17.
Driscoll, James P., Ignacio Aliagas, Jennifer J. Harris, et al.. (2010). Formation of a Quinoneimine Intermediate of 4-Fluoro-N-methylaniline by FMO1: Carbon Oxidation Plus Defluorination. Chemical Research in Toxicology. 23(5). 861–863. 9 indexed citations
18.
Choo, Edna F., James P. Driscoll, Jian Q. Feng, et al.. (2009). Disposition of GDC-0879, a B-RAF kinase inhibitor in preclinical species. Xenobiotica. 39(9). 700–709. 8 indexed citations
19.
Kalgutkar, Amit S., James P. Driscoll, Sabrina X. Zhao, et al.. (2007). A Rational Chemical Intervention Strategy To Circumvent Bioactivation Liabilities Associated with a Nonpeptidyl Thrombopoietin Receptor Agonist Containing a 2-Amino-4-arylthiazole Motif. Chemical Research in Toxicology. 20(12). 1954–1965. 38 indexed citations
20.
Driscoll, James P., et al.. (2007). Bioactivation of Phencyclidine in Rat and Human Liver Microsomes and Recombinant P450 2B Enzymes: Evidence for the Formation of a Novel Quinone Methide Intermediate. Chemical Research in Toxicology. 20(10). 1488–1497. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Kent Rinehart Breakdown of academic impact, for papers by Paresh K. Patel Breakdown of academic impact, for papers by Yan Xia Breakdown of academic impact, for papers by James Mitroka Breakdown of academic impact, for papers by Faraz Kazmi Breakdown of academic impact, for papers by Giovanni Cianchetta Breakdown of academic impact, for papers by Ellen A. Cannady Breakdown of academic impact, for papers by Michelle K. Dennehy Breakdown of academic impact, for papers by Adria Colletti Breakdown of academic impact, for papers by Olaf Kuhlmann
Rankless by CCL
2026